Posted in | News | Gold

Riverstone Resources Reports Further Assays from Karma Project

Riverstone Resources has announced the assay results from the additional seven holes drilled at the Kao zone, which is located in the company's Karma Gold project in West Africa.

Kao Main Zone - 2011 Drill Program

This drill program comes under a current 90,000 m program at the Karma project, which has been planned to validate the reverse circulation (RC) drilling results, and has authenticated the mineralization continuity. It has expanded the mineralization along the strike and to depth.

The company has outlined the mineralization at the Kao zone over a distance of more than 800 m to the north-south and 800 m towards down-dip to the eastern part. The deposit stays open to the north-east and down-dip. Numerous satellite zones are yet to be drill tested.

Riverside has intersected 5.80 g/t gold over 4 m and 1.52 g/t gold over 20 m in hole DD-028, 1.70 g/t gold over 10 m and 1.06 g/t gold over 38 m in hole DD-030, 1.37 g/t gold over 18 m in hole DD-033 and 2.44 g/t gold over 14 m in hole DD-034.

M.D. McInnis, Riverstone’s CEO, stated that the company is delighted that the diamond drill program at the KOA mineralization is uniform along the down dip and strike. It authenticated and advanced the RC results. This drilling campaign is part of the upcoming plan of completing a 2012 Preliminary Economic Study.

This deposit is part of the Karma project, which includes a NI 43-101 compliant gold resource estimate. Riverside has drilled a further +40,000 m at the Karma project and it is anticipating that the drilling results will be added to the overall resource.

Source: http://www.riverstoneresources.com/

Joel Scanlon

Written by

Joel Scanlon

Joel relocated to Australia in 1995 from the United Kingdom and spent five years working in the mining industry as an exploration geotechnician. His role involved utilizing GIS mapping and CAD software. Upon transitioning to the North Coast of NSW, Australia, Joel embarked on a career as a graphic designer at a well-known consultancy firm. Subsequently, he established a successful web services business catering to companies across the eastern seaboard of Australia. It was during this time that he conceived and launched News-Medical.Net. Joel has been an integral part of AZoNetwork since its inception in 2000. Joel possesses a keen interest in exploring the boundaries of technology, comprehending its potential impact on society, and actively engaging with AI-driven solutions and advancements.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Riverstone Resources Inc.. (2019, February 18). Riverstone Resources Reports Further Assays from Karma Project. AZoMining. Retrieved on May 03, 2024 from https://www.azomining.com/News.aspx?newsID=5542.

  • MLA

    Riverstone Resources Inc.. "Riverstone Resources Reports Further Assays from Karma Project". AZoMining. 03 May 2024. <https://www.azomining.com/News.aspx?newsID=5542>.

  • Chicago

    Riverstone Resources Inc.. "Riverstone Resources Reports Further Assays from Karma Project". AZoMining. https://www.azomining.com/News.aspx?newsID=5542. (accessed May 03, 2024).

  • Harvard

    Riverstone Resources Inc.. 2019. Riverstone Resources Reports Further Assays from Karma Project. AZoMining, viewed 03 May 2024, https://www.azomining.com/News.aspx?newsID=5542.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.